Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,280
Total Claims
$935K
Drug Cost
880
Beneficiaries
$1,063
Cost/Patient
Risk Score Breakdown 32/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+36%
Opioid rate vs peers
47.2% vs 34.8% avg
+152%
Cost per patient vs peers
$1,063 vs $422 avg
+37%
Brand preference vs peers
6.5% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
47.2%
Opioid Rate
5,791
Opioid Claims
$348K
Opioid Cost
15.7%
Long-Acting Rate
This provider's opioid prescribing rate of 47.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 793 claims · $565K
Generic: 11,487 claims · $370K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Methylnaltrexone Bromide | 86 | $210K |
| Oxycodone Hcl | 139 | $105K |
| Oxycodone Hcl/Acetaminophen | 1,923 | $59K |
| Hydrocodone/Acetaminophen | 2,037 | $46K |
| Lidocaine | 104 | $43K |
| Lidocaine | 373 | $43K |
| Oxymorphone Hcl | 40 | $39K |
| Linaclotide | 70 | $38K |
| Erenumab-Aooe | 36 | $27K |
| Naloxegol Oxalate | 63 | $26K |
| Diclofenac Sodium | 430 | $26K |
| Gabapentin | 1,343 | $21K |
| Oxycodone Myristate | 34 | $21K |
| Gabapentin | 19 | $19K |
| Chlorzoxazone | 63 | $16K |
Prescribing Profile
60
Unique Drugs
32.0
Anomaly Score
Patient Profile
67
Avg Age
71%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About